NIH Issues Clinical Trial Transparency Proposal; Expands Submissions to Results From Unapproved Products, Requires Detailed Adverse Event Information – Policy & Medicine
Clinical trial transparency & patient centricity | By TrialScope | Facebook
Investigators' sense of failure thwarted transparency in clinical trials discontinued for poor recruitment - Journal of Clinical Epidemiology
Clinical Trials transparency is failing - here's why - BMJ EBM Spotlight
Clinical Trial Cost Transparency at the NIH: Law and Policy Recommendations | NYU School of Law
U.S. Toughens Rules for Clinical-Trial Transparency - Scientific American
Lilly Trials
European research funders often fail to monitor clinical trial transparency
Medidata is a Leader in Clinical Trial Transparency for Patients & Partners - Medidata Solutions
Importance of Sharing Clinical Trial Data for Drug Development
New study documents the harm caused by evidence distortion in medical research
Final Rule on Clinical Trial Transparency: Will it be Enough to Encourage More Compliance? | RAPS
Clinical Trial Transparency: Ensuring Compliance with the New FDA Guidelines | BrackenData Clinical Trial Intelligence
Clinical trial transparency: 'There is no one answer to what must be disclosed'
Are the new clinical trial transparency rules incompatible with the patentability requirements in Europe? | Nature Biotechnology
Transparency is needed for Covid-19 vaccine trials - STAT
Cochrane Sweden collaborates on trial transparency report | Cochrane
New EU Protocol Aims to Improve Clinical Trial Transparency | The Scientist Magazine®
Transparency in clinical trials is a must!
UK Abuzz With Action On Clinical Trial Transparency :: Pink Sheet
Transparency and the European Medicines Agency — Sharing of Clinical Trial Data | NEJM
